Free Trial

Salarius Pharmaceuticals (SLRX) SEC Filings & 10K Form

Salarius Pharmaceuticals logo
$1.44 +0.04 (+2.86%)
(As of 11/21/2024 ET)

Recent Salarius Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/01/2024
4:05 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEFA14A
11/01/2024
4:04 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEF 14A
09/27/2024
3:01 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
4:10 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
4:01 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B5
07/25/2024
4:03 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
4:25 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B5
07/19/2024
4:13 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
7:15 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:05 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:11 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B5
04/12/2024
3:50 PM
Arthur David J. (Reporting)
Salarius Pharmaceuticals, Inc. (Issuer)
Salarius Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
3:03 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEF 14A
03/26/2024
3:05 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEFA14A
03/15/2024
4:00 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form PRE 14A
02/22/2024
3:16 PM
Lammers Paul (Reporting)
Salarius Pharmaceuticals, Inc. (Issuer)
Salarius Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:21 PM
Lieber Jonathan I (Reporting)
Salarius Pharmaceuticals, Inc. (Issuer)
Salarius Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners